findmyKOL

Malissa Wood, MD

Enriched profile

Vice President and Chief Physician Executive, Lee Health Heart Institute · Lee Health Heart Institute

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Fort Myers, FL · Southeast · United StatesSpecialtyCardiovascular DiseaseFocusCoronary Artery Disease / ACS
Active KOLLatest publication2024Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Malissa Wood is Vice President and Chief Physician Executive, Lee Health Heart Institute at Lee Health Heart Institute. OpenAlex indexes 188 publications with 8,664 citations (h-index 42); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 15 Oct 2026

Overview

Updated 16 Oct 2026

Malissa J. Wood, MD, is Vice President and Chief Physician Executive, Lee Health Heart Institute. The public record shows 188 publications with 8,664 citations (h-index 42), centered on Coronary Artery Disease / ACS. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 13 companies.

  • Most recent indexed publication: 2024 · European heart journal. Case reports
  • Top research focus: Coronary Artery Disease / ACS
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 13 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Coronary Artery Dissection, Spontaneous1 trialCoronary Artery Disease / ACS1 trialMicrovascular Angina1 trial

Research focus

OpenAlex concept fingerprint
Coronary Artery Disease / ACS

Drugs & molecules

across trials, industry payments and publications
Rinvoqgeneric · UpadacitinibClinical trials—Industry payments27Publications—Rezdiffrageneric · ResmetiromClinical trials—Industry payments20Publications—Skyrizigeneric · RisankizumabClinical trials—Industry payments11Publications—Multaqgeneric · DronedaroneClinical trials—Industry payments1Publications—Vyndaqelgeneric · TafamidisClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments67Heartflow, Inc.Clinical trials—Industry payments61Pfizer Inc.Clinical trials—Industry payments27Madrigal PharmaceuticalsClinical trials—Industry payments20AbiomedClinical trials—Industry payments10Edwards Lifesciences CorporationClinical trials—Industry payments9Medtronic, Inc.Clinical trials—Industry payments3Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments2E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Kestra Medical Technology Services, Inc.Clinical trials—Industry payments1Massachusetts General HospitalClinical trials1Industry payments—Sanofi-Aventis U.S. LLCClinical trials—Industry payments1SCAD AllianceClinical trials1Industry payments—ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
188publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

8,664citations

Total citations across indexed works.

42h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
13companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record
  • Chair

    American College of Cardiology Board of Governors and Secretary, ACC Board of Trustees

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org ↗
  • Chief Medical Officer

    Women As One (nonprofit advancing equity for women in medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →womenasone.org ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    100%
    Statin67.5%
    Atorvastatin Calcium59%Simvastatin41%
    Part D<11 patients
    Beta blocker32.5%
    Metoprolol Succinate100%
    Part D≥11 patients
Where care is delivered (Part B), 202368.7% facility · 31.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    health.usf.edu/medicine/internalmedicine/cardiology/faculty/crousillatd

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usf.edu ↗
  • X / Twitter

    X/Twitter: @drmalissawood

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
  • LinkedIn

    LinkedIn: linkedin.com/in/malissa-wood-1607b010 (lists role at Women As One)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.